Thu, Nov 27, 2014, 9:03 PM EST - U.S. Markets closed for Thanksgiving Day

Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies, Inc. Message Board

charttrendzz 10 posts  |  Last Activity: Nov 21, 2014 10:12 AM Member since: Sep 23, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Apparently, some people on this board expect a reverse stock split to help entice funds to take positions in BCLI, the goal being an increase in the stock price, a good thing. Besides in actuality, if you take a historical look at these scenarios, unless the stock has earning behind it, the price will continue to degrade. (Please point out to me cases to the contrary.) Now more importantly, look at the dynamics of the market. We know that now a days large blocks of stock are arranged purchases with the specialist or MM, or more commonly done in dark pools. We see this all the time that large dark pool purchases are made for stocks that join an index and there is HUGE volume but often little movement in the stock price. CUR recently had a large increase in fund purchases, over 10 million new positions and the stock price actually went down. Let the news develop and have the LARGER small investors and funds, who don't use these mechanisms drive up the stock price. It will happen.

    Bottom line, either BCLI has a winning treatment, if so, the stock price will climb dramatically. A ton of smaller funds will take positions. If the treatment is "so so", then let the company do a reverse stock split for insiders, but at a much latter stage like closer to commercialization. I wonder if Lebovits has faith in this company, he needs some emunah based on this reverse stock split talk. All IMHO. GL longs!

  • Reply to

    who got the best tech

    by nirkim12 Aug 31, 2014 7:42 AM
    charttrendzz charttrendzz Aug 31, 2014 10:59 AM Flag

    Both are winners. BCLI will probably get FDA approval first, since its perceived as a safer treatment (using the patients own bone marrow). Big plus is that BCLI is selling at 1/5 the market cap of CUR's current undervalued price. Bottom line both have fantastic stock growth opportunities.

  • Reply to

    who got the best tech

    by nirkim12 Aug 31, 2014 7:42 AM
    charttrendzz charttrendzz Sep 3, 2014 10:24 AM Flag

    The results start wearing off after a few months but the improvement is dramatic and the patients respond faster with each injection. Check the graphs from their recent presentation. My nephew takes a needle DAILY for growth hormone injections. A periodic OP clinic visit every 6 months for an injection may be in the cards for this type of treatment. BCLI does not require an IP over night encounter like CUR. Both have hopeful processes and I wish both companies luck and success with finding a cure.

  • Reply to

    who got the best tech

    by nirkim12 Aug 31, 2014 7:42 AM
    charttrendzz charttrendzz Sep 3, 2014 10:24 AM Flag

    The results start wearing off after a few months but the improvement is dramatic and the patients respond faster with each injection. Check the graphs from their recent presentation. My nephew takes a needle DAILY for growth hormone injections. A periodic OP clinic visit every 6 months for an injection may be in the cards for this type of treatment. BCLI does not require an IP over night encounter like CUR. Both have hopeful processes and I wish both companies luck and success with finding a cure.

  • charttrendzz charttrendzz Sep 8, 2014 10:37 AM Flag

    I agree, CUR seems to have more potential with a very exciting pipeline. But I think BCLI will get FDA approval first based on safety, but who knows, both are very interesting companies. In any case, BCLI is selling at a fraction to CUR prior to any news. The question is who will win the price race, BCLI hitting $1.20 or CUR hitting $15? I have positions in both.

  • charttrendzz charttrendzz Sep 9, 2014 10:53 AM Flag

    Hope I'm wrong regarding this reverse split (I usually sell a stock when I'm in "hope" mode.). I had a personal target of $1.50 for BCLI over the next couple of years let's see if $22 now happens. This target is based on the market cap of CUR and the loss of value by CYTK.

  • charttrendzz charttrendzz Sep 9, 2014 10:53 AM Flag

    Hope I'm wrong regarding this reverse split (I usually sell a stock when I'm in "hope" mode.). I had a personal target of $1.50 for BCLI over the next couple of years let's see if $22 now happens. This target is based on the market cap of CUR and the loss of value by CYTK.

  • Reply to

    Looking at the slides...

    by joe_vish Sep 10, 2014 2:44 PM
    charttrendzz charttrendzz Sep 10, 2014 4:46 PM Flag

    Makes people smarter but it also has a side effect, seems to grow hair on people's heads.

  • Very positive news, regardless of the market. A great stock to own. I've been in Jazz and I'm hoping to see this stock blow JAZZ's stock price appreciation out of the sky.

  • Been in this pullback channel, upper range is approaching recent resistance. I think a move above $3.10 with volume should get us back to the $4 area, IMHO. My alerts are waiting for $3.10 to fall.

SIGA
1.66+0.010(+0.61%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.